Holdings of Simplify Propel Opportunities ETF
Simplify Exchange Traded Funds
· 37 declared positions · as of Mar 31, 2026
Original filing · Net assets 69.4M $ · Ten largest lines: 75.2 % of the equity sleeve
Sector breakdown
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 90.5 %
- CA 2.7 %
- CH 2.6 %
- FR 1.9 %
- GB 1.3 %
- DK 0.8 %
- KY 0.2 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|
| US | 31 | 61.1M $ | 90.49 % |
| CA | 1 | 1.8M $ | 2.66 % |
| CH | 1 | 1.8M $ | 2.63 % |
| FR | 1 | 1.3M $ | 1.87 % |
| GB | 1 | 879.6K $ | 1.30 % |
| DK | 1 | 568.8K $ | 0.84 % |
| KY | 1 | 139.8K $ | 0.21 % |
Positions
| Company | Shares | Value | Weight |
|---|
| Plains GP Holdings LP | 1,272,360 | 30.9M $ | 44.55 % |
| ACHIEVE LIFE SCIENCES INC | 1,184,512 | 3.5M $ | 5.02 % |
| Phathom Pharmaceuticals Inc | 262,386 | 2.9M $ | 4.20 % |
| Delcath Systems Inc | 261,126 | 2.4M $ | 3.49 % |
| Abeona Therapeutics Inc | 500,342 | 2.2M $ | 3.23 % |
| Celldex Therapeutics Inc | 68,994 | 2.2M $ | 3.16 % |
| Milestone Pharmaceuticals Inc | 1,506,405 | 1.8M $ | 2.58 % |
| Oculis Holding AG | 66,667 | 1.8M $ | 2.56 % |
| LeonaBio Inc | 149,279 | 1.5M $ | 2.21 % |
| Corcept Therapeutics Inc | 37,763 | 1.5M $ | 2.20 % |
| Kyverna Therapeutics Inc | 173,106 | 1.5M $ | 2.15 % |
| Inventiva SACA | 227,923 | 1.3M $ | 1.82 % |
| Viridian Therapeutics Inc | 56,231 | 1.1M $ | 1.59 % |
| Aquestive Therapeutics Inc | 234,279 | 972.3K $ | 1.40 % |
| Vor BioPharma Inc | 53,510 | 954.6K $ | 1.38 % |
| Orchestra BioMed Holdings Inc | 219,387 | 932.4K $ | 1.34 % |
| Zevra Therapeutics Inc | 96,246 | 897K $ | 1.29 % |
| Compass Pathways plc | 159,052 | 879.6K $ | 1.27 % |
| Trevi Therapeutics Inc | 65,412 | 780.4K $ | 1.13 % |
| Ocular Therapeutix Inc | 90,000 | 762.3K $ | 1.10 % |
| SAB Biotherapeutics Inc | 187,230 | 717.1K $ | 1.03 % |
| Upstream Bio Inc | 77,793 | 700.1K $ | 1.01 % |
| EyePoint Inc | 53,526 | 690K $ | 0.99 % |
| 4D Molecular Therapeutics Inc | 70,430 | 655.7K $ | 0.95 % |
| Palisade Bio Inc | 350,000 | 612.5K $ | 0.88 % |
| Zealand Pharma A/S | 12,330 | 568.8K $ | 0.82 % |
| KALARIS THERAPEUTICS INC | 87,426 | 504.4K $ | 0.73 % |
| IMMUNIC INC | 438,932 | 487.2K $ | 0.70 % |
| Coherus Oncology Inc | 253,140 | 427.8K $ | 0.62 % |
| Akero Therapeutics Inc | 145,609 | 426.6K $ | 0.62 % |
| Corvus Pharmaceuticals Inc | 20,242 | 296.1K $ | 0.43 % |
| Ovid therapeutics Inc | 130,813 | 290.4K $ | 0.42 % |
| Artiva Biotherapeutics Inc | 23,230 | 149.6K $ | 0.22 % |
| CONNECT BIOPHARMA HOLDINGS LTD | 53,375 | 139.8K $ | 0.20 % |
| Chinook Therapeutics Inc | 25,000 | 2.5K $ | 0.00 % |
| Eiger BioPharmaceuticals Inc | 90,000 | 900 $ | 0.00 % |
| Achieve Life Science Inc | 966,667 | 1 $ | |